TY - JOUR
KW - Analgesics, Opioid/adverse effects
KW - Humans
KW - Mass Screening
KW - Opioid-Related Disorders/diagnosis/drug therapy
KW - Primary Health Care
KW - Reproducibility of Results
KW - internal medicine
KW - Pain Management
KW - Substance misuse
AU - C. Timko
AU - K. Kroenke
AU - A. Nevedal
AU - M. C. Lor
AU - E. Oliva
AU - K. Drexler
AU - F. Sandbrink
AU - K. Hoggatt
A1 - 
AD - Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, California, USA ctimko@stanford.edu.; Department of Veterans Affairs, Menlo Park, California, USA.; Indiana University Center for Health Services and Outcomes Research, Indianapolis, Indiana, USA.; Department of Veterans Affairs, Menlo Park, California, USA.; Department of Veterans Affairs, Menlo Park, California, USA.; Program Evaluation and Resource Center, Department of Veterans Affairs, Menlo Park, California, USA.; Veterans Health Administration, Washington, DC, USA.; Emory University School of Medicine, Atlanta, Georgia, USA.; Veterans Health Administration, Washington, DC, USA.; George Washington University, Washington, DC, USA.; Department of Medicine, University of California, San Francisco, California, USA.; Department of Veterans Affairs, San Francisco, California, USA.
BT - BMJ open
C5 - Measures; Opioids & Substance Use
CP - 10
DO - 10.1136/bmjopen-2021-053524
IS - 10
JF - BMJ open
LA - eng
M1 - Journal Article
PB - . Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ
PY - 2021
SN - 2044-6055; 2044-6055
T1 - Development and field testing of primary care screening tools for harms of long-term opioid therapy continuation and tapering to discontinuation: a study protocol
T2 - BMJ open
TI - Development and field testing of primary care screening tools for harms of long-term opioid therapy continuation and tapering to discontinuation: a study protocol
U1 - Measures; Opioids & Substance Use
U2 - 34620670
U3 - 10.1136/bmjopen-2021-053524
VL - 11
VO - 2044-6055; 2044-6055
Y1 - 2021
Y2 - Oct 7
ER -